A citation-based method for searching scientific literature

James R Fuller, Kevin E Knockenhauer, Nina C Leksa, Robert T Peters, Joseph D Batchelor. Blood 2021
Times Cited: 3







List of co-cited articles
2 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


BIVV001, a new class of factor VIII replacement for hemophilia A that is independent of von Willebrand factor in primates and mice.
Ekta Seth Chhabra, Tongyao Liu, John Kulman, Susannah Patarroyo-White, Buyue Yang, Qi Lu, Douglas Drager, Nancy Moore, Jiayun Liu, Amy M Holthaus,[...]. Blood 2020
28
66

Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A.
Steven W Pipe, Robert R Montgomery, Kathleen P Pratt, Peter J Lenting, David Lillicrap. Blood 2016
93
66

Assembly Mechanism of Mucin and von Willebrand Factor Polymers.
Gabriel Javitt, Lev Khmelnitsky, Lis Albert, Lavi Shlomo Bigman, Nadav Elad, David Morgenstern, Tal Ilani, Yaakov Levy, Ron Diskin, Deborah Fass. Cell 2020
29
33

Interaction Between the a3 Region of Factor VIII and the TIL'E' Domains of the von Willebrand Factor.
Lisbeth Dagil, Kathrin S Troelsen, Gert Bolt, Lars Thim, Bo Wu, Xin Zhao, Edward G D Tuddenham, Thomas E Nielsen, David A Tanner, Johan H Faber,[...]. Biophys J 2019
4
33

Shielding of the A1 domain by the D'D3 domains of von Willebrand factor modulates its interaction with platelet glycoprotein Ib-IX-V.
Hans Ulrichts, Miklós Udvardy, Peter J Lenting, Inge Pareyn, Nele Vandeputte, Karen Vanhoorelbeke, Hans Deckmyn. J Biol Chem 2006
103
33

The von Willebrand factor D'D3 assembly and structural principles for factor VIII binding and concatemer biogenesis.
Xianchi Dong, Nina C Leksa, Ekta Seth Chhabra, Joseph W Arndt, Qi Lu, Kevin E Knockenhauer, Robert T Peters, Timothy A Springer. Blood 2019
30
33

Visualization of an N-terminal fragment of von Willebrand factor in complex with factor VIII.
Andrew Yee, Austin N Oleskie, Anne M Dosey, Colin A Kretz, Robert D Gildersleeve, Somnath Dutta, Min Su, David Ginsburg, Georgios Skiniotis. Blood 2015
29
33

Mapping the interaction between factor VIII and von Willebrand factor by electron microscopy and mass spectrometry.
Po-Lin Chiu, George M Bou-Assaf, Ekta Seth Chhabra, Melissa G Chambers, Robert T Peters, John D Kulman, Thomas Walz. Blood 2015
37
33

Recombinant VWF fragments improve bioavailability of subcutaneous factor VIII in hemophilia A mice.
Nadine Vollack-Hesse, Olga Oleshko, Sonja Werwitzke, Barbara Solecka-Witulska, Christoph Kannicht, Andreas Tiede. Blood 2021
3
33

Central venous access devices for paediatric patients with haemophilia: a single-institution experience.
R Titapiwatanakun, C Moir, R K Pruthi, P L Stavlo, K A Schmidt, V Rodriguez. Haemophilia 2009
21
33

Novel forms of B-domain-deleted recombinant factor VIII molecules. Construction and biochemical characterization.
P Lind, K Larsson, J Spira, M Sydow-Bäckman, A Almstedt, E Gray, H Sandberg. Eur J Biochem 1995
99
33

Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia.
Marilyn J Manco-Johnson, Thomas C Abshire, Amy D Shapiro, Brenda Riske, Michele R Hacker, Ray Kilcoyne, J David Ingram, Michael L Manco-Johnson, Sharon Funk, Linda Jacobson,[...]. N Engl J Med 2007
33

Hemophilia therapy: the future has begun.
Pier Mannuccio Mannucci. Haematologica 2020
57
33

Subcutaneous engineered factor VIIa marzeptacog alfa (activated) in hemophilia with inhibitors: Phase 2 trial of pharmacokinetics, pharmacodynamics, efficacy, and safety.
Johnny Mahlangu, Howard Levy, Marina V Kosinova, Heghine Khachatryan, Bartosz Korczowski, Levani Makhaldiani, Genadi Iosava, Martin Lee, Frank Del Greco. Res Pract Thromb Haemost 2021
1
100

A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study).
A Gringeri, B Lundin, S von Mackensen, L Mantovani, P M Mannucci. J Thromb Haemost 2011
331
33

Preclinical pharmacokinetics and biodistribution of subcutaneously administered glycoPEGylated recombinant factor VIII (N8-GP) and development of a human pharmacokinetic prediction model.
F Rode, K Almholt, M Petersen, M Kreilgaard, M Kjalke, D M Karpf, A V Groth, P B Johansen, L F Larsen, M Loftager,[...]. J Thromb Haemost 2018
4
33

Design of a prospective observational study on the effectiveness and real-world usage of recombinant factor VIII Fc (rFVIIIFc) compared with conventional products in haemophilia A: the A-SURE study.
Johannes Oldenburg, Charles R M Hay, Víctor Jiménez-Yuste, Flora Peyvandi, Jean-François Schved, Johan Szamosi, Bent Winding, Stefan Lethagen. BMJ Open 2019
5
33

TPO for ITP in pregnancy.
James B Bussel, Eun-Ju Lee. Blood 2017
3
33


Pharmacokinetics, immunogenicity, safety, and preliminary efficacy of subcutaneous turoctocog alfa pegol in previously treated patients with severe hemophilia A (alleviate 1).
Robert Klamroth, Clemens Feistritzer, Ute Friedrich, Steven R Lentz, Kirsten Reichwald, Marek Zak, Pratima Chowdary. J Thromb Haemost 2020
7
33

FVIII at the crossroad of coagulation, bone and immune biology: Emerging evidence of biological activities beyond hemostasis.
Marie Cadé, Javier Muñoz-Garcia, Antoine Babuty, Marc Fouassier, Marie-Francoise Heymann, Paul E Monahan, Dominique Heymann. Drug Discov Today 2022
2
50

BIVV001 Fusion Protein as Factor VIII Replacement Therapy for Hemophilia A.
Barbara A Konkle, Amy D Shapiro, Doris V Quon, Janice M Staber, Roshni Kulkarni, Margaret V Ragni, Ekta S Chhabra, Stacey Poloskey, Kara Rice, Suresh Katragadda,[...]. N Engl J Med 2020
21
33

New concepts in von Willebrand disease.
J Evan Sadler. Annu Rev Med 2005
119
33

Emicizumab Prophylaxis in Hemophilia A with Inhibitors.
Johannes Oldenburg, Johnny N Mahlangu, Benjamin Kim, Christophe Schmitt, Michael U Callaghan, Guy Young, Elena Santagostino, Rebecca Kruse-Jarres, Claude Negrier, Craig Kessler,[...]. N Engl J Med 2017
466
33


Emicizumab: Review of the literature and critical appraisal.
E Carlos Rodriguez-Merchan, Leonard A Valentino. Haemophilia 2019
23
33





Establishing the Prevalence and Prevalence at Birth of Hemophilia in Males: A Meta-analytic Approach Using National Registries.
Alfonso Iorio, Jeffrey S Stonebraker, Hervé Chambost, Michael Makris, Donna Coffin, Christine Herr, Federico Germini. Ann Intern Med 2019
99
33

von Willebrand factor antigen latex immunoassays are affected to a different extent by rheumatoid factor.
Agota Schlammadinger, Karen Vanhoorelbeke, Pal Laszlo, Zsuzsa Bereczky, Laszlo Muszbek, Hans Deckmyn, Zoltan Boda. Clin Appl Thromb Hemost 2006
4
33

Clinical problem-solving. A bloody mystery.
Adam Cuker, Jean M Connors, Joel T Katz, Bruce D Levy, Joseph Loscalzo. N Engl J Med 2009
11
33

The relationship between ABO blood group, von Willebrand factor, and primary hemostasis.
Soracha E Ward, Jamie M O'Sullivan, James S O'Donnell. Blood 2020
19
33

Signaling through GP Ib-IX-V activates alpha IIb beta 3 independently of other receptors.
Ana Kasirer-Friede, Maria Rita Cozzi, Mario Mazzucato, Luigi De Marco, Zaverio M Ruggeri, Sanford J Shattil. Blood 2004
133
33

Platelet alpha-granules: basic biology and clinical correlates.
Price Blair, Robert Flaumenhaft. Blood Rev 2009
569
33

Von Willebrand disease type 2N: An update.
Omid Seidizadeh, Flora Peyvandi, Pier Mannuccio Mannucci. J Thromb Haemost 2021
5
33


Sequence and structure relationships within von Willebrand factor.
Yan-Feng Zhou, Edward T Eng, Jieqing Zhu, Chafen Lu, Thomas Walz, Timothy A Springer. Blood 2012
164
33

ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders.
F Rodeghiero, A Tosetto, T Abshire, D M Arnold, B Coller, P James, C Neunert, D Lillicrap. J Thromb Haemost 2010
405
33

Automated assays for von Willebrand factor activity.
Russell A Higgins, Andrew J Goodwin. Am J Hematol 2019
15
33


Validation of an automated latex particle-enhanced immunoturbidimetric von Willebrand factor activity assay.
D Chen, J I Tange, B J Meyers, R K Pruthi, W L Nichols, J A Heit. J Thromb Haemost 2011
32
33

ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease.
Paula D James, Nathan T Connell, Barbara Ameer, Jorge Di Paola, Jeroen Eikenboom, Nicolas Giraud, Sandra Haberichter, Vicki Jacobs-Pratt, Barbara Konkle, Claire McLintock,[...]. Blood Adv 2021
60
33

Weibel-Palade bodies at a glance.
Jessica J McCormack, Mafalda Lopes da Silva, Francesco Ferraro, Francesca Patella, Daniel F Cutler. J Cell Sci 2017
42
33

Clinically relevant differences between assays for von Willebrand factor activity.
J Boender, J Eikenboom, J G van der Bom, K Meijer, J de Meris, K Fijnvandraat, M H Cnossen, B A P Laros-van Gorkom, W L van Heerde, E P Mauser-Bunschoten,[...]. J Thromb Haemost 2018
15
33


Factor VIII/VWF complex caught on camera.
Emma-Ruoqi Xu, Jonas Emsley. Blood 2021
1
100

Platelet Disorders.
Kristina M Haley. Pediatr Rev 2020
1
100

Association of ABO(H) and I blood group system development with von Willebrand factor and Factor VIII plasma levels in children and adolescents.
Dieter Klarmann, Christine Eggert, Christof Geisen, Sabine Becker, Erhard Seifried, Thomas Klingebiel, Wolfhart Kreuz. Transfusion 2010
31
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.